These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9182689)

  • 1. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.
    Frei K; Eugster HP; Bopst M; Constantinescu CS; Lavi E; Fontana A
    J Exp Med; 1997 Jun; 185(12):2177-82. PubMed ID: 9182689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for lymphotoxin in experimental allergic encephalomyelitis.
    Suen WE; Bergman CM; Hjelmström P; Ruddle NH
    J Exp Med; 1997 Oct; 186(8):1233-40. PubMed ID: 9334362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
    Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB
    J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
    Gommerman JL; Giza K; Perper S; Sizing I; Ngam-Ek A; Nickerson-Nutter C; Browning JL
    J Clin Invest; 2003 Sep; 112(5):755-67. PubMed ID: 12952924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis.
    Kassiotis G; Pasparakis M; Kollias G; Probert L
    Eur J Immunol; 1999 Mar; 29(3):774-80. PubMed ID: 10092079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.
    Powell MB; Mitchell D; Lederman J; Buckmeier J; Zamvil SS; Graham M; Ruddle NH; Steinman L
    Int Immunol; 1990; 2(6):539-44. PubMed ID: 1707660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.
    Amor S; Groome N; Linington C; Morris MM; Dornmair K; Gardinier MV; Matthieu JM; Baker D
    J Immunol; 1994 Nov; 153(10):4349-56. PubMed ID: 7525700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
    Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
    Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some misconceptions about understanding autoimmunity through experiments with knockouts.
    Steinman L
    J Exp Med; 1997 Jun; 185(12):2039-41. PubMed ID: 9221283
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
    Santambrogio L; Hochwald GM; Saxena B; Leu CH; Martz JE; Carlino JA; Ruddle NH; Palladino MA; Gold LI; Thorbecke GJ
    J Immunol; 1993 Jul; 151(2):1116-27. PubMed ID: 8335893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and efficient regimen for producing chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) in SJL mice.
    Yang J; Lindal S; Ylinen E; Setälä N; Hukkanen V; Seljelid R
    APMIS; 1999 Aug; 107(8):800-6. PubMed ID: 10515131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
    Terényi N; Nagy N; Papp K; Prechl J; Oláh I; Erdei A
    Mol Immunol; 2009 Nov; 47(1):57-63. PubMed ID: 19201476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice.
    Sean Riminton D; Körner H; Strickland DH; Lemckert FA; Pollard JD; Sedgwick JD
    J Exp Med; 1998 May; 187(9):1517-28. PubMed ID: 9565643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
    Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.